Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I thought September was the month to hear from the Doctors. Well It must be September 2021. I will still be hear with all my shares. No option.
They have serval billion shares issued and I have 5 million of them. There.
Is this stock dead or what?
CRICKETS
Is it a deal or no deal? Every attempt I have made to contact the new Management has been in vain.
AM I Rich yet?
Big Question, Should I buy more shares? Or should I be worried about all the shares that exist already?
I guess I own Private Company common shares now.
No need to move on if you are stuck. I am stuck waiting for relief.
GTX) Selling something New.
https://app.getresponse.com/view.html?x=a62b&m=nWWjy&mc=JC&s=ZX5Vo&u=SqPb&z=EydMhBU&
To the contrary from an actual user here. It worked on me and my dog.
Ut Oh:
https://www.sec.gov/news/press-release/2020-212
SEC Emblem
U.S. SECURITIES AND EXCHANGE COMMISSION
ABOUT
DIVISIONS & OFFICES
ENFORCEMENT
REGULATION
EDUCATION
FILINGS
NEWS
Newsroom Left Nav
Newsroom
Press Releases
Public Statements
Speeches
Testimony
Spotlight Topics
Media Kit
Press Contacts
Events
Webcasts
What's New
Media Gallery
RSS Feeds
Social Media
Press Release
SEC Adopts Amendments to Enhance Retail Investor Protections and Modernize the Rule Governing Quotations for Over-the-Counter Securities
FOR IMMEDIATE RELEASE
2020-212
Washington D.C., Sept. 16, 2020 —
The Securities and Exchange Commission today adopted amendments to Exchange Act Rule 15c2-11, an important component of the over-the-counter (OTC) market regulatory structure. The amendments are designed to modernize the rule, which was last substantively amended nearly thirty years ago, including to recognize advances in communications technologies. The amended rule enhances disclosure and investor protection in the OTC market by ensuring that broker-dealers, in their role as professional gatekeepers to this market, do not publish quotations for an issuer’s security when current issuer information is not publicly available, subject to certain exceptions.
“These retail investor-focused improvements to Rule 15c2-11 are long overdue,” said SEC Chairman Jay Clayton. “The technological advancements that have taken place since the rule was last amended enable us to require that information in the OTC market be more timely, enabling investors to make better informed investment decisions, and reducing fraud in these markets where retail presence is significant and, unfortunately, pump-and-dump and other frauds are too common.”
“The amended rule represents another important step in our tireless and proactive efforts to protect retail investors from being victimized by microcap fraud,” said Stephanie Avakian, Director of the Division of Enforcement.
Brett Redfearn, Director of the Division of Trading and Markets, said that “the amendments strike the right balance between promoting critically important investor protections while at the same time providing new exceptions that should make it easier for certain securities to develop a quoted market.”
Securities that trade on the OTC market are primarily owned by retail investors. Because broker-dealers play an integral role in facilitating access to OTC securities and serve an important gatekeeper function, Rule 15c2-11 requires broker-dealers to review key, basic issuer information before initiating or resuming quotations for the issuer’s security in the OTC market.
Prior to today’s amendments, certain of the rule’s previous exceptions permitted broker-dealers to maintain a quoted market for an issuer’s security in perpetuity, in the absence of current and publicly available information about the issuer, and even when the issuer no longer exists. Recognizing the ease with which information sharing takes place today, the amendments generally prohibit broker-dealers from publishing quotations for an issuer’s security when issuer information is not current and publicly available, subject to certain exceptions. Investors who have access to current and publicly available issuer information are better equipped to make informed decisions about how to allocate their capital and to counteract misinformation that can proliferate through promotions and other channels.
The amendments also are designed to enhance the efficiency of the OTC market and facilitate capital formation for issuers for which information is current and publicly available. Specifically, the amendments add new exceptions for certain OTC securities that may be less susceptible to fraud or manipulation, such as actively traded securities of well-capitalized issuers, and expand the scope of market participants that may comply with the rule’s required review of issuer information.
* * *
FACT SHEET
Publication or Submission of Quotations Without Specified Information
Amendments
Rule 15c2-11 (the "Rule") governs the publication or submission of quotations by broker-dealers in a quotation medium other than a national securities exchange. Before a broker-dealer may initiate or resume quotations for a security in a quotation medium, the broker-dealer must review key, basic information about the issuer of the security. The Rule allows any qualified interdealer quotation system (“qualified IDQS”) to conduct the required information review as well.
The amendments are designed to modernize the Rule to (1) provide greater transparency to investors and other market participants by requiring that information about the issuer and its security be current and publicly available before a broker-dealer can begin quoting that security; (2) limit broker-dealers’ reliance on certain of the Rule’s exceptions when issuer information is not current and publicly available; and (3) provide exceptions to reduce unnecessary burdens on broker-dealers to quote certain OTC securities that may be less susceptible to fraud and manipulation.
The amendments facilitate transparency of OTC issuer information by:
Requiring to be current and publicly available certain specified documents and information regarding OTC issuers that a broker-dealer or qualified IDQS must obtain and review for the broker-dealer to commence a quoted market in an OTC issuer’s security (“information review requirement”);
Updating the “piggyback” exception, which allows broker-dealers to rely on the quotations of another broker-dealer that initially complied with the information review requirement, to require, among other things, that issuer information, depending on the issuer’s regulatory status, be current and publicly available, timely filed, or filed within 180 calendar days from a specified period; and
Requiring that issuer information be current and publicly available for a broker-dealer to rely on the unsolicited quotation exception to publish quotations on behalf of company insiders and affiliates of the issuer.
The amendments provide greater investor protections when broker-dealers rely on the piggyback exception by:
Requiring at least a one-way priced quotation;
Prohibiting reliance on the exception during the first 60 calendar days following the termination of a Commission trading suspension under Section 12(k) of the Exchange Act; and
Providing a time-limited window of 18 months during which broker-dealers may quote the securities of “shell companies.”
The amendments reduce unnecessary burdens on broker-dealers by:
Allowing broker-dealers to initiate a quoted market for a security if a qualified IDQS complies with the information review requirement and makes a publicly available determination of such compliance; and
Providing new exceptions, without undermining the Rule’s important investor protections, for broker-dealers to:
Quote actively traded securities of well-capitalized issuers;
Quote securities issued in an underwritten offering if the broker-dealer is named as an underwriter in the registration statement or offering statement for the underwritten offering, and the broker-dealer that is the named underwriter quotes the security; and
Rely on certain third-party publicly available determinations that the requirements of certain exceptions are met.
The amendments also streamline and remove outdated provisions from the Rule. The Commission is also issuing guidance that provides basic principles and examples of red flags to facilitate compliance with the information review requirement.
What’s Next?
The Rule will become effective 60 days following publication of the amendments in the Federal Register. The Rule will have a general compliance date that is nine months after the effective date as well as a compliance date that is two years after the effective date regarding provisions to require an issuer’s financial information for the last two fiscal years to be current and publicly available.
###
MAYBE THE CONTROLLERS OF THIS THREAD COULD UPDATE THE COMPANY INFO PAGE AND GET RID OF THE PAST. PLEASE PUT THE NEW COMPANY ON THE BOARD. I BELIEVE IT HAS TO DO WITH THE MEDICAL FIELD.
ALL FACTS POINT TO NPHC BECOMING A HUGE GAINER
I hope it becomes worth a lot as I have a lot invested here. $30,682.33 to be exact.
Blueberry Fields Forever!!! Da Da Da!
Can't we just get along?
Why would Ric need a lawyer when he did nothing wrong. Trumped up charges to try and bring down little Pharma. Bid boys at play here and using the US Government to do their dirty work all along we taxpayers fund it for them.
Yes it came from here.
Yes it came in an email to me.
I hate to have to agree, but it had only raised $100,000 as of shown report. I would still love for this stock to rise in spike of any ill feelings toward Jim Bickel.
This post is interesting. I read only 6% of US deaths were directly due to Covid. We all know the Hospitals were inflating the numbers to get a government paycheck for each patient. What is this stuff about getting relisted or our money back? More details please.
Aston88, It turned out to be a huge sell.
Meanwhile back at the Ranch. Here is Rick. Coming soon to Walmart.
CDC put information out the only 6% of all Covid-19 Recorded deaths in US were actually due to Covid-19. The rest died from other underlying issues. Not as deadly as they has us all believing and slowed the economy due to false alarm. IMO and from what I have read. Masks and all the PPE stuff will have had their day soon enough.
No big deal, they need to focus on technology anyway.
Me Too, I am with you skyrocketinsight.
VGTL is not a Scam, it is a Stock Symbol. An active Stock Symbol, Last I looked.
Not a Scam, but a Slow Poke, when it comes to getting my investment to pay off. A real Turtle.
What is going on with XFTB. Up to .0012 this morning? Heavy Volume.
Thanks Myth.
Thanks for your thoughts. I am not happy with Jim B. either. Wish I would of sold with a profit way back when.
Myth, Do you have any idea if anything positive for this stock? Just curious as an investor not trader, my bad.
Not while I have my money still in it!
Newbauer found the deal and I bet retired some of the CD's.
I heard you could not short a penny stock. Maybe not true?
Yes I know you have been casting doubt. I just want to see something happen even if it is another company that takes over.
It sure seems as if the New Acquiring Company is AWOL. Gone not responding to requests for information. What gives? Need Answers. And Quick.
Yes, Welcome back, I have not sold one share and sure do need this stock to rise from the ashes in a big way to get even.
Yes, I know that they were working with them in some way, but I did not know about the 10% stake. Thanks
Great Marketing Add.